DE3012249A1 - Prostaglandinderivate - Google Patents

Prostaglandinderivate

Info

Publication number
DE3012249A1
DE3012249A1 DE19803012249 DE3012249A DE3012249A1 DE 3012249 A1 DE3012249 A1 DE 3012249A1 DE 19803012249 DE19803012249 DE 19803012249 DE 3012249 A DE3012249 A DE 3012249A DE 3012249 A1 DE3012249 A1 DE 3012249A1
Authority
DE
Germany
Prior art keywords
hydroxymethyl
decarboxy
deoxy
pgf
hydroxy
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
DE19803012249
Other languages
German (de)
English (en)
Inventor
John Charles Sih
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pharmacia and Upjohn Co
Original Assignee
Upjohn Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US06/026,066 external-priority patent/US4243611A/en
Priority claimed from US06/025,899 external-priority patent/US4228104A/en
Application filed by Upjohn Co filed Critical Upjohn Co
Publication of DE3012249A1 publication Critical patent/DE3012249A1/de
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/93—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems condensed with a ring other than six-membered
    • C07D307/935—Not further condensed cyclopenta [b] furans or hydrogenated cyclopenta [b] furans
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00—Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00—Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
    • C07C405/0008—Analogues having the carboxyl group in the side-chains replaced by other functional groups
    • C07C405/0016—Analogues having the carboxyl group in the side-chains replaced by other functional groups containing only hydroxy, etherified or esterified hydroxy groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00—Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
    • C07C405/0008—Analogues having the carboxyl group in the side-chains replaced by other functional groups
    • C07C405/0025—Analogues having the carboxyl group in the side-chains replaced by other functional groups containing keto groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00—Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
    • C07C405/0008—Analogues having the carboxyl group in the side-chains replaced by other functional groups
    • C07C405/0041—Analogues having the carboxyl group in the side-chains replaced by other functional groups containing nitrogen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/28—Phosphorus compounds with one or more P—C bonds
    • C07F9/38—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
    • C07F9/40—Esters thereof
    • C07F9/4003—Esters thereof the acid moiety containing a substituent or a structure which is considered as characteristic
    • C07F9/4015—Esters of acyclic unsaturated acids

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DE19803012249 1979-04-02 1980-03-28 Prostaglandinderivate Withdrawn DE3012249A1 (de)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US2587879A 1979-04-02 1979-04-02
US2587979A 1979-04-02 1979-04-02
US06/026,066 US4243611A (en) 1979-04-02 1979-04-02 2-Decarboxy-2-hydroxymethyl-19,20-didehydro PG2 compounds
US06/025,899 US4228104A (en) 1979-04-02 1979-04-02 2-Decarboxy-2-hydroxymethyl-19-hydroxy-PG1 analogs

Publications (1)

Publication Number Publication Date
DE3012249A1 true DE3012249A1 (de) 1980-10-16

Family

ID=27487451

Family Applications (1)

Application Number Title Priority Date Filing Date
DE19803012249 Withdrawn DE3012249A1 (de) 1979-04-02 1980-03-28 Prostaglandinderivate

Country Status (4)

Country Link
DE (1) DE3012249A1 (OSRAM)
FR (1) FR2453152A1 (OSRAM)
GB (1) GB2048254B (OSRAM)
IT (1) IT1141908B (OSRAM)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5238961A (en) * 1990-06-14 1993-08-24 Allergan, Inc. Pgf 1-alcohols and their use as ocular hypotensives
US5139491A (en) * 1990-12-06 1992-08-18 Allergan, Inc. 2-decarboxyl-2-alkoxyalkyl prostaglandins as ocular hypotensives
IL145122A0 (en) 1999-03-05 2002-06-30 Procter & Gamble C16 unsaturated fp-selective prostaglandin analogs
US6894175B1 (en) 1999-08-04 2005-05-17 The Procter & Gamble Company 2-Decarboxy-2-phosphinico prostaglandin derivatives and methods for their preparation and use
US20020172693A1 (en) 2000-03-31 2002-11-21 Delong Michell Anthony Compositions and methods for treating hair loss using non-naturally occurring prostaglandins
US20020037914A1 (en) 2000-03-31 2002-03-28 Delong Mitchell Anthony Compositions and methods for treating hair loss using C16-C20 aromatic tetrahydro prostaglandins
US20020013294A1 (en) 2000-03-31 2002-01-31 Delong Mitchell Anthony Cosmetic and pharmaceutical compositions and methods using 2-decarboxy-2-phosphinico derivatives
US8623918B2 (en) 2008-10-29 2014-01-07 Novaer Holdings, Inc. Amino acid salts of prostaglandins
US8722739B2 (en) 2008-10-29 2014-05-13 Novaer Holdings, Inc. Amino acid salts of prostaglandins

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4036876A (en) * 1973-07-13 1977-07-19 Syntex (U.S.A.) Inc. 18- AND 19-Hydroxylated prostaglandins
GB1499018A (en) * 1974-09-19 1978-01-25 Sankyo Co Pharmaceutically useful prostenoic acid derivatives
US4127612A (en) * 1978-03-17 1978-11-28 Miles Laboratories, Inc. 19-Hydroxy PGE1 carbinol analogues
IT1131550B (it) * 1979-07-05 1986-06-25 Upjohn Co Derivati prostaciclinici

Also Published As

Publication number Publication date
IT1141908B (it) 1986-10-08
GB2048254A (en) 1980-12-10
FR2453152B1 (OSRAM) 1985-04-12
IT8021050A0 (it) 1980-03-28
FR2453152A1 (fr) 1980-10-31
GB2048254B (en) 1983-05-25

Similar Documents

Publication Publication Date Title
EP0059158B1 (de) Azaprostacycline, Verfahren zu ihrer Herstellung und ihre pharmazeutische Verwendung
DE2659215A1 (de) Prostaglandin-analoga
DE2704933A1 (de) Prostaglandin-analoga mit dreifachbindung zwischen c-13 und c-14 und verfahren zu ihrer herstellung
CH647222A5 (de) 9-desoxy-9a-methylen-isostere von pgi-2 und verfahren zu deren herstellung.
DE2313868A1 (de) 11-deoxyprostaglandinderivate und deren herstellungsverfahren
DE2904655A1 (de) Prostacyclinanaloga
DE3306123A1 (de) Neue carbacycline, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
DE2627674A1 (de) Prostaglandinartige 1,11-lactone und ein verfahren zu ihrer herstellung
DE3012249A1 (de) Prostaglandinderivate
EP0051558B1 (de) Prostacyclinderivate, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
DE2658207A1 (de) Prostaglandinanaloga und verfahren zu deren herstellung
EP0069692B1 (de) Neue Carbacycline, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
DE2627672A1 (de) Prostaglandinartige 1,15-lactone und verfahren zu deren herstellung
DE2659216A1 (de) Prostaglandin-analoga
CH634831A5 (en) Process for the preparation of optically active or racemic prostaglandins.
DE2659217A1 (de) Prostaglandin-analoga
DE2719901A1 (de) Pge- und 11-deoxy-pge-verbindungen mit einer methylengruppe am c-9
DE2724555A1 (de) 5,6-dihydro-prostacyclin-analoge und verfahren zu deren herstellung
EP0086404B1 (de) Neue Carbacycline, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
DE2830478C2 (de) Prostaglandin-Analoge
DE2746932A1 (de) 5,9-cyclische aether von 9-deoxy- prostaglandin-f tief 1alpha -artigen verbindungen und verfahren zu deren herstellung
DE2847049C2 (de) 13,14-Didehydro-prostaglandine, Verfahren zu ihrer Herstellung und sie enthaltendes pharmazeutisches oder veterinärmedizinisches Mittel
DE2704932A1 (de) Prostaglandin-analoga mit dreifachbindung zwischen c-13 und c-14 und verfahren zu ihrer herstellung
CH623570A5 (OSRAM)
DE2704958A1 (de) Prostaglandin-analoga mit dreifachbindung zwischen c-13 und c-14 und verfahren zu ihrer herstellung

Legal Events

Date Code Title Description
8128 New person/name/address of the agent

Representative=s name: HENKEL, G., DR.PHIL. FEILER, L., DR.RER.NAT. HAENZ

8141 Disposal/no request for examination